05/02/2026
Is your dissolution method struggling with challenging formulations?
๐ตModified release tablets.
๐ตPoorly soluble APIs.
๐ตLow media volumes.
These are exactly where conventional dissolution methods start to struggle. Thatโs why more pharma labs are turning to flow-through cell testing (USP Apparatus 4) the method originally pioneered by SOTAX Group and now widely trusted for challenging formulations.
As the sole authorized distributor of SOTAX in Malaysia, we see this shift happening locally too. Especially for:
โ๏ธ Extended / controlled-release products
โ๏ธ Early formulation development
โ๏ธ Method development for difficult APIs
โ๏ธ Studies requiring tight hydrodynamic control
Modern systems like CE 7smart make this advanced technique more accessible, reproducible, and compliance-ready for routine lab use, not just research.
If dissolution results have been inconsistent, or your product doesnโt behave well in Apparatus 1 & 2โฆ this might be the method your lab actually needs.
Comment "USP4" below, and our team will send you a technical guide on when to make the switch!
&D